Amphiregulin couples IL1RL1(+) regulatory T cells and cancer-associated fibroblasts to impede antitumor immunity

por Sun, Runzi, Zhao, Hongyu, Gao, David Shihong, Ni, Andrew, Li, Haochen, Chen, Lujia, Lu, Xinghua, Chen, Kong, Lu, Binfeng
Publicado 2023

The Half-Life-Extended IL21 can Be Combined With Multiple Checkpoint Inhibitors for Tumor Immunotherapy

por Wu, Shaoxian, Sun, Runzi, Tan, Bo, Chen, Bendong, Zhou, Wenyan, Gao, David Shihong, Zhong, Joshua, Huang, Hao, Jiang, Jingting, Lu, Binfeng
Publicado 2021

Synergism Between IL21 and Anti-PD-1 Combination Therapy is Underpinned by the Coordinated Reprogramming of the Immune Cellular Network in the Tumor Microenvironment

por Wu, Shaoxian, Huang, Hao, Sun, Runzi, Gao, David Shihong, Ye, Fan, Huang, Jianing, Li, Ella, Ni, Andrew, Lu, Kevin GuoKai, Chen, Kong, Jiang, Jingting, Morel, Penelope A., Zhong, Ziyang, Lu, Binfeng
Publicado 2023